Clinical Trial Update: Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for cervical cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma
• Malignant Neoplasm

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Squamous Cell Carcinoma, Adenosquamous Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2021-02-03